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Objective: Oral cenesthopathy is characterized by foreign body sensations without medical 
and dental evidence for them. It is thought to be a rare disease in psychiatry, but many patients 
are visiting dental clinics seeking treatment to remove a foreign body. Even though the features 
of oral cenesthopathy might be different between a psychiatric clinic and a dental clinic, there 
has been no clinico-statistical study from dentists. In this study, we report a clinico-statistical 
study of patients with oral cenesthopathy in dentistry. 
Methods: This is a retrospective chart review of 606 outpatients with oral cenesthopathy in 
Tokyo Medical and Dental University from April 2010 through to March 2015. 
Results: A total of 159 male and 447 female patients were included in this study. The mean age 
was 62.08 years, and female patients were older than male patients. The trigger of the dental 
treatment and the acute phase of depression at the onset were significantly related (p=0.037). 
Only 128 patients (36%) had clinically significant improvement after 6 months of pharmaco-
therapy. No history of psychiatric disorders (odds ratio [OR] 0.479 [95% confidence interval 
{CI}: 0.262–0.875], p=0.017) and longer duration of illness (.18 months) (OR 2.626 [95% 
CI: 1.437–4.799], p=0.002) were significant factors for clinical outcomes. 
Conclusion: Patients with oral cenesthopathy in our clinic were predominantly elderly female 
patients. Dental treatment in the acute phase of depression might be a risk factor for oral cenest-
hopathy. Therefore, comprehending the situation of psychiatric disorder and obtaining adequate 
informed consent might be required to prevent the trouble concerning oral cenesthopathy.
Keywords: oral cenesthopathy, delusional disorder somatic type, DDST, chart review, 
dentistry
Introduction
Cenesthopathy is characterized by foreign body sensations despite the lack of any 
medical evidence for them.1,2 Oral cavity is the most affected region of cenesthopathy, 
and it is called “oral cenesthopathy,”3–5 “oral somatic delusions,” or “oral dysesthesia.”6 
There are various complaints of oral cenesthopathy. Some patients complain of unusual 
oral sensations, such as excessive mucus secretion or a slimy sensation, and others 
complain of a bizarre oral sensation, such as a feeling of coils or wires being present 
within the oral region. Patients commonly have an unshakable conviction that some 
foreign body is existing in their mouths. They often spend hours each day examining 
their mouth and sometimes try to catch the foreign body. To prove the abnormal sen-
sations to be real, they sometimes show “the specimen sign:”7 taking specimens such 
as saliva or dental plaque and collecting them in a bottle or plastic case (Figure 1). 
Sometimes the patients with oral cenesthopathy had other comorbid psychosomatic 
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oral symptoms including burning mouth syndrome (BMS). 
Normally oral cenesthopathy does not induce pain symptom, 
which is different from BMS.
The patients tend to avoid seeing psychiatrists even if the 
dentists suggest to visit them, because they have a firm con-
viction that the foreign body is real. When the complaints are 
obviously a delusion or hallucination developed by psychotic 
diseases, it is not difficult for dentists to consult the patients 
to psychiatrists. However, many patients without obvious 
psychotic diseases exist in dental clinics seeking treatment 
to remove the foreign body.6
In such situations, it is said that oral cenesthopathy is a 
rare disorder, and most of the cases are a secondary symp-
tom of depression or schizophrenia; however, such studies 
were reported by psychiatrists.8–10 From the viewpoint of 
psychiatry, the oral symptoms were sometimes suspected as 
a side effect of prescription drugs. Even though the clinical 
features of oral cenesthopathy might be different between a 
psychiatric clinic and a dental clinic, to the best of our knowl-
edge, there has been no clinico-statistical study from dentists. 
To delineate the clinical features of oral cenesthopathy in 
dentistry, we herein report a clinico-statistical study on the 
patients with oral cenesthopathy in our clinic.
Patients and methods
Data collection and ethical approval
Data for individual patients diagnosed as having oral 
cenesthopathy in our clinic between April 2010 and 
March 2015 were retrospectively and consecutively collected. 
Oral cenesthopathy was diagnosed by a specialist in 
psychosomatic dentistry who had examined the patients 
over 25 years and certified by Japanese society of psy-
chosomatic dentistry (AT). The inclusion criteria were as 
follows: 1) an outpatient of our clinic, 2) complaining of a 
bizarre or strange sensation in the mouth, and 3) absence of 
corresponding abnormal findings from a dental panoramic 
radiograph and intra- and-extra-oral examination. Patients 
who did not give us the written consent for this study 
were excluded.
Epidemiological profiles, features of symptoms, original 
referrer, comorbid oral psychosomatic disorders, and psychi-
atric history were documented. In the features of symptoms, 
we checked the trigger, the reason which the patients think 
to develop the symptom of oral cenesthopathy. State of 
depression at the onset of oral cenesthopathy was checked 
if the patients had a history of depression. The diagnosis of 
psychiatric disorders and state of depression were inves-
tigated by obtaining referral letters from the psychiatrists. 
The outcomes of our treatments were also documented if 
the patients continued to visit our clinic. 
This study is approved by the institutional review boards 
of Tokyo Medical and Dental University dental hospital 
(approval number: 356). Written informed consent was 
provided by all patients before the study.
Treatment protocol and assessment
Psychotherapy and pharmacotherapy are the mainstream 
treatments for oral cenesthopathy. Antidepressants and 
Figure 1 “specimen sign” of a patient with oral cenesthopathy.
Notes: (A) “sticky liquid’’ coming from the patient’s palate was collected in a bottle and brought to our clinic. (B) “White powder from the gum of the upper jaw’’ was 
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retrospective chart review of oral somatic delusions
antipsychotic drugs were prescribed in our clinic depending 
on the patients’ symptoms, medical complications, former 
reports,11–16 personality features, and background such as life-
style, habits, income, opportunity, and family relationships. 
If dental treatment was needed during our treatment, their 
family dentists or attending dentists in our clinic (YU, AM, 
YS, LM, SS, KK, TT, TW, TS, MW, MT, and TY) treated 
them while confirming their symptoms. In cases where the 
patients had primary psychiatric disorders, we contacted their 
psychiatrist and observed their symptoms every 1–3 months, 
as possible. When severe psychiatric disorders were devel-
oped during our treatment, we consulted the psychiatrists 
who cooperated.
The relationship between oral cenesthopathy and depres-
sion was classified into three types: 1) “onset after depres-
sion,” the onset of oral cenesthopathy was during depression 
treatment; 2) “simultaneous,” the onsets of oral cenesthopa-
thy and depression were simultaneous; and 3) “onset before 
depression,” the depression developed after the onset of oral 
cenesthopathy. In addition, the “onset after depression” group 
was divided into two subgroups if the onset of oral cenest-
hopathy was during the “acute phase” or “recovery phase” 
of depression, which were assessed by referral letters from 
attending psychiatrists.
We defined “acute phase” in this study as the period 
when the symptoms of depression were aggravated or not 
stable and with repeated fluctuation. The prescriptions were 
not fixed as well. Likewise, “recovery phase” was defined as 
the period when no or mild residual symptoms of depression 
were observed due to the effective treatment.
The outcomes were assessed by each attending dentist 
by using the clinical global impression improvement scale 
(CGI-I)17 after 6 months of treatment. CGI-I scores range 
from 0 to 7 (0, not assessed; 1, very much improved; 2, much 
improved; 3 minimally improved; 4, no change; 5, minimally 
worse; 6, much worse; and 7, very much worse). CGI-I scores 
were calibrated before evaluation among the raters. CGI-I 
scores of 1 and 2 were thought to be a clinically significant 
improvement.
statistical analysis
Mann–Whitney U test and chi-square test were used for 
comparing each variable. A chi-square test was used for 
the association between the trigger of oral cenesthopathy 
and the phase of depression. Logistic regression analysis 
was performed to detect the clinical factors for a good 
outcome. Sex, age at the time of onset, duration of illness, 
expression of the symptom, psychiatric history, and trigger 
of the symptom were selected for inclusion in the binomial 
logistic regression analysis. All analyses were performed 
with PASW 17.0 software (IBM Corporation, Armonk, NY, 




Table 1 shows the demographic and clinical characteristics 
of the patients. In total, 606 patients were included in this 
study of which 159 were male and 447 female patients. 
The mean ages were 62.08 years in total, 58.69 years in the 
male patients, and 63.28 years in the female patients. The 
distributions of the male and female patients are shown in 
Figure 2. The mean duration of illness at the time of first 
examination was 40.12 months. As to the comorbidity 
of other psychosomatic dental symptoms, BMS, atypical 
odontalgia, phantom bite syndrome, and halitophobia were 
seen in 159 patients (26%), 35 patients (6%), 27 patients 
(4%), and 4 patients (1%), respectively, including multiple 
Table 1 Demographic and clinical characteristics of patients
Characteristic
gender, N (male/female) 606 (159/447)
age (year), mean (sD) 62.08 (12.44)
Duration of illness, m, mean (sD) 40.12 (48.42)
Other comorbid psychosomatic dental symptoms
Burning mouth syndrome (cumulative number (%)) 159 (26.24)
atypical odontalgia (cumulative number (%)) 35 (5.78)
Phantom bite syndrome (cumulative number (%)) 27 (4.46)
halitosis (cumulative number (%)) 4 (0.66)
Nothing (cumulative number (%)) 409 (67.49)
Original referrer
Family physician (cumulative number (%)) 253 (40.29)
Psychiatry (cumulative number (%)) 245 (39.01)
Otorhinolaryngology (cumulative number (%)) 35 (5.57)
surgery (cumulative number (%)) 28 (4.46)
Neurology (cumulative number (%)) 19 (3.03)
Ophthalmology (cumulative number (%)) 11 (1.75)
gynecology (cumulative number (%)) 8 (1.27)
Other departments (cumulative number (%)) 7 (1.11)
Nothing (cumulative number (%)) 22 (3.50)
Comorbid psychiatric disorders
Depression (cumulative number (%)) 157 (24.69)
Bipolar disorder (cumulative number (%)) 26 (4.09)
schizophrenia (cumulative number (%)) 13 (2.04)
Neurosis (cumulative number (%)) 124 (19.50)
Others (cumulative number (%)) 33 (5.19)
Unknown (cumulative number (%)) 36 (5.94)
Nothing (cumulative number (%)) 247 (38.84)
Trigger of the symptom
spontaneous (cumulative number (%)) 379 (62.54)
Dental treatment (cumulative number (%)) 181 (29.87)
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diagnosis. There were various original referrers. Family 
physicians were the most common (n=253), followed by 
psychiatry (n=245), otorhinolaryngology (n=35), surgery 
(n=28), neurology (n=19), ophthalmology (n=11), gynecol-
ogy (n=8), other departments (n=7), and nothing (n=22) 
including multiple referrers. 
As to the psychiatric comorbidity, which was described 
in the referral letter, patients with no history of psychiatric 
disorder were the most common (38%). Psychotic disorders 
including schizophrenia and bipolar disorder were only 6%. 
Although depression was seen in 26%, almost all of them 
were in recovery phase. With regard to the trigger of the 
symptom, “spontaneous” was seen in 379 patients (63%), 
“dental treatment” was 181 patients (30%), and “the others” 
were 46 patients (8%). “The others” included drug change 
and intra-oral change such as stomatitis, traffic accident, and 
surgical treatment outside of the oral region. With regard to 
the “dental treatment,” various treatments including tooth 
extraction (n=38), dental implants (n=21), prosthodontic 
treatment (n=49), restoration (n=21), endodontics (n=14), 
periodontics (n=18), bite adjustment (n=8), and other treat-
ments (n=12) were described (Table 2). 
There were various symptoms. Some foreign body sensa-
tion was seen in 208 patients (34.3%). A sticky sensation, rough 
sensation, and sucking sensation were seen in 221 (36.5%), 
54 (8.9%), and 64 patients (10.6%), respectively. Taste dis-
turbance and dry mouth which were self-reported were seen 
in 204 (33.7%) and 120 patients (19.8%), respectively.
Male–female comparison
To assess the differences between male and female patients, 
each variable, which is mentioned above, was analyzed 
(Table 3). Mean age, mean duration of illness, number of 
other comorbid psychosomatic oral symptoms with oral 
cenesthopathy, number of comorbid psychiatric disorders, 
and number of onsets with dental treatment were compared 
between male and female patients. A Mann–Whitney U test 
revealed that the female patients were significantly older 
than male patients (p=0.001), and a Pearson’s chi-square 
test showed that the frequency of other comorbid psychoso-
matic oral symptoms was significantly higher in the female 
patients (p=0.0005).
Young–old comparison
In addition, to assess the differences between young and old 
patients, each variable was analyzed, using age =60 years as 
the cutoff value. Sex, mean duration of illness, number of 
onsets with dental treatment, number of comorbid psychi-
atric disorders, and symptoms were compared. A Pearson’s 
chi-square test revealed that being female ( p=0.017) and 
a sticky sensation were significantly dominated in elderly 
patients ( p=0.003). Also, the differences between the 
patients of early onset and the other patients were scrutinized. 
The patients whose onset of the symptom were at an age 
of ,30 years were male dominant (p,0.001) and complain-
ing sucking sensation (p,0.001) but neither sticky sensation 
(p=0.003) nor taste disturbance (p=0.033), compared to the 
other patients.
Figure 2 Distribution of male and female patients.
Notes: White and gray bars show the numbers of male and female patients, 
respectively. The numbers of patients in each age group are described beside the bars. 
The distributions are mono-modal with the peak in their 60s in both the patients.
Table 2 Details of the dental treatments that are considered to 
trigger the symptoms
Dental treatment Cases, n (%)
extraction 38 (21.0)
Dental implant 21 (11.6)
Fixed denture 34 (18.8)
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retrospective chart review of oral somatic delusions
Obviously bizarre complaints and 
relatively understandable complaints
Another interesting point is differences in the themes of 
delusions of cenesthopathy. The contents of delusions 
vary from patient to patient. Some patients have obviously 
bizarre delusional complaints such as “a moving coil in the 
oral cavity,” so any doctor or dentist can easily notice their 
strange contents. On the other hand, other patients complain 
that saliva or bubbles, normally existing in the oral cavity, 
are extraordinary in some ways, so some doctors or dentists 
may not notice their delusions. Then, we divided the patients 
into two groups (patients with obviously bizarre complaints 
and others) with respect to the content of complaints and 
compared them. Of the 606 cases, 211 patients had obviously 
bizarre delusional complaints. As to clinical factors such as 
age (p=0.188, non significant [ns]), sex (p=0.792, ns), dura-
tion of illness (p=0.352, ns), comorbid psychiatric disorders 
(p=0.898, ns), and onset of the symptom (p=0.271, ns), no 
significant differences were detected between the two groups. 
Furthermore, the treatment outcomes of both the groups were 
compared. In patients with obviously bizarre complaints, 
41 patients were improved and 78 were unimproved, whereas 
in other patients, 87 patients were improved and 146 were 
unimproved. A Pearson’s chi-square test revealed no signifi-
cant difference between the two groups (p=0.64, ns).
relationship between the trigger of oral 
cenesthopathy and depression phase at 
onset
Because depression is the most common disease among 
comorbid psychiatric disorders, we next focused on the 
relationship between the onset of oral cenesthopathy and the 
state of depression. Referring to the referral letter, patients 
who were comorbid with depression were classified into 
four types: “onset after depression,” “simultaneous,” “onset 
before depression,” and “unknown.” More than three quarters 
of cenesthopathic patients with depression developed the 
oral symptoms during depression treatment (n=120, 77%). 
“Onset before depression,” “simultaneous” onset, and 
“unknown” were seen in 11%, 2%, and 10%, respectively 
(Figure 3). In the “onset after depression” group, 80 patients 
were in “recovery phase,” and 40 patients were in “acute 
phase” at the time of onset of oral cenesthopathy.
A Pearson’s chi-square test between the trigger of 
the symptom (spontaneous and dental treatment) and the 
history of depression (depression and no psychiatric history) 
showed no significant difference (p=0.49, ns). On the other 
hand, a Pearson’s chi-square test between the trigger of the 
symptom (spontaneous and dental treatment) and the phase 
of depression at the onset (recovery and acute phase) detected 
a significant difference (p=0.037) (Table 4). 
logistic regression analysis of treatment 
outcomes 
Next, the clinical outcomes after 6 months of treatment 
were analyzed using the CGI-I score (Figure 4). A total 
of 352 patients could be followed up over 6 months. Only 
128 patients (36%) had clinically significant improvements. 
In line with former studies, the overall outcomes were not 
satisfactory. Logistic regression analysis revealed that 
no history of psychiatric disorder (odds ratio [OR] 0.479 
Table 3 Differences between male and female patients
Male Female p-value
age (year), mean (sD)* 58.69 (14.09) 63.28 (11.57) 0.001
Duration of illness (months), mean (sD) 36.35 (47.50) 41.46 (48.73) ns
Other comorbid psychosomatic dental symptoms* 35 (22.01%) 164 (36.69%) 0.0005
comorbid psychiatric disorders 91 (57.23%) 263 (58.84%) ns
Onset with dental treatment 52 (25.16%) 175 (32.21%) ns
Notes: Mann–Whitney U test; *p,0.05.
Abbreviation: ns, nonsignificant.
Figure 3 state of depression at the onset of oral cenesthopathy.
Notes: The number of patients with oral cenesthopathy after depression was 120 
(77%). eighteen patients developed depression after the onset of oral cenesthopathy. 
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[95% confidence interval {CI}: 0.262–0.875], p=0.017) and 
longer duration of illness (.18 months) (OR 2.626 [95% CI: 
1.437–4.799], p=0.002) were significant factors for clinical 
outcomes (Table 5). Therefore, any history of psychiatric 
disorder and longer duration of illness over 18 months are 
significant risk factors for a poor prognosis. The reliability of 
this binomial logistic regression analysis was checked with 
the Hosmer and Lemeshow test (p=0.306).
effective drugs for oral cenesthopathy
Of the aggregate data from improved patients whose CGI-I 
score were 1 or 2, 94 patients were prescribed in our depart-
ment and the rest of them (n=34) were prescribed by their 
attending psychiatrist. The most prescribed medicine was 
aripiprazole (n=56) including monotherapy and combination 
therapy. The mean dosage of aripiprazole was 1.52 mg/day. 
In some cases, mirtazapine (n=15), amitriptyline (n=9), 
perospirone (n=1), tetracyclic antidepressants (n=9), SNRI 
(n=5), and SSRI (n=6) were effective.
Discussion
In this retrospective study, we described the epidemiological 
and clinical features of oral cenesthopathy, the risk factors for 
the onset of oral cenesthopathy, the outcomes, and the risk 
factors for a poor prognosis. It is the first retrospective chart 
review for oral cenesthopathy in dentistry. The patients in this 
study maintained enough social skills to come to our clinic 
regularly as scheduled, though some of them had comorbid 
psychiatric disorders.
Patients with oral cenesthopathy in our clinic were 
predominantly elderly female patients. The mean age was 
62 years, and the male patients were significantly younger 
than female patients. In a study4 for oral cenesthopathy 
consisting of three men and 25 women, the mean age was 
55.1 years. A review18 collecting several studies of cenesthop-
athy, including that outside of the oral region, reported that 
oral symptoms are more frequent in patients aged .40 years 
and are more common in female patients in this age group. 
The gross distribution of the present study was similar to 
former studies. Compared to other clinical entities similar 
to oral cenesthopathy, such as delusional infestation or 
delusional parasitosis, which was reported to be observed 
in elderly patients who were aged .50 years, male patients 
were younger than female patients. In addition, other comor-
bid psychosomatic dental symptoms were more common in 
female patients. This seemed to be due in part to the biological 
characteristics of psychosomatic oral symptoms, which were 
originally female dominant.19
There are various symptoms: some patients complained 
that a real object such as a wire, metal, or finger was exist-
ing, and others complained of the feeling of something about 
to spout out or a spontaneous taste. From the viewpoint of 
psychiatry, only obviously delusional complaints tend to be 
regarded as oral cenesthopathy, so such a large number of 
oral cenesthopathy patients in this study might be difficult 
to believe. In our clinic, however, not just delusional but 
bizarre complaints such as “excessive saliva secretion” and 
“a sticky sensation in the mouth” were included in oral cen-
esthopathy. These complaints are commonly understandable, 
so psychiatrists do not have the chance to see such patients. 
Figure 4 course of oral cenesthopathy after 6 months of treatment using the 
clinical global impression improvement score.
Notes: a total of 352 patients were followed up over 6 months. Only 128 patients 
(36%) had a clinically significant improvement.
Table 4 relationship between the trigger of oral cenesthopathy 




recovery phase* 20 56 76
acute phase* 17 20 37
sum 37 76 113
Notes: Pearson’s chi-square test; *p,0.05.






sex (female) 1.127 0.594 2.138 0.715
age at the time of onset 1.588 0.863 2.922 0.137
Duration of illness (.18 months)* 2.626 1.437 4.799 0.002
Obvious bizarre complaints 1.042 0.564 1.927 0.894
No history of mental disorder* 0.479 0.262 0.875 0.017
Onset with dental treatment 1.142 0.594 2.195 0.691
Note: *p,0.05.
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retrospective chart review of oral somatic delusions
Assuming psychiatrists see such patients, the two types of 
complaints (obviously delusional/relatively understand-
able) might be classified under different diagnosis (somatic 
delusion/somatic symptom disorder). But they are bizarre 
enough to be diagnosed as oral cenesthopathy based on our 
clinical experience. In fact, no significant differences were 
detected between the delusional complaints and other factors 
including sex, age, and history of depression. Moreover, 
the complaints did not reflect the treatment outcome at all. 
Therefore, the expression of complaints might not indicate 
the category in oral cenesthopathy. The obviously bizarre 
complaints did not necessarily anticipate a worse clinical 
course. Thus, although patients with oral cenesthopathy 
complain of various clinical symptoms, from an apparently 
abnormal experience that no one can believe, seemingly to 
a usual malfunction such as excessive mucus secretion or a 
slimy sensation, they essentially seem to be categorized into 
the same disease. Originally, it is difficult to categorize oral 
cenesthopathy using the Diagnostic and Statistical Manual 
of Mental Disorders, Fifth edition (DSM5).20 Delusional 
disorder, somatic type (DDST) is the best category for oral 
cenesthopathy so far, but it does not fit this disorder satis-
factorily. DDST is the only one that was not included in 
Kraepelin’s original description of paranoia,21 and no discus-
sion was made about whether oral cenesthopathy should be 
described as delusion or not. In Europe, delusional parasitosis 
is generally believed to represent a primary hallucination 
with an accompanying secondary delusion that explains the 
sensory perception, whereas in the United States, the sensory 
phenomena associated with delusional parasitosis are viewed 
as components of a systematized and encapsulated delusion.21 
Most of our patients seem to be polite and have no problem in 
their social skills or interpersonal relationships. They usually 
complain about their strange symptoms plangently or in a 
detached tone and ask us to remove their troublesome sensa-
tions. Also, they occasionally notice that their complaints 
are very strange and unacceptable to others.
Intuitively, they try to express their strange perception in 
the oral cavity as precisely as possible, sometimes resulting in 
showing “the specimen sign” in order to explain. Thus, some 
patients with oral cenesthopathy in our clinic might have a 
perceptual dysfunction (illusion or hallucination) rather than 
delusion. In fact, our study, which revealed the asymmetrical 
regional cerebral blood flow (rCBF) between the right and 
left side,22 might suggest a micro disorder in a sensory path-
way. Therefore, some patients with oral cenesthopathy, at 
least in our clinic, might be appropriate to be categorized 
into “organic hallucinosis (F06.0 in ICD-10)” rather than 
“delusional disorder, somatic type (DDST).” 
Around 40% of patients in this study had no psychiatric 
histories. Moreover, while some patients had a history of 
depression, they were mostly in remission at the time of onset 
of oral cenesthopathy. Therefore, oral cenesthopathy might 
not be merely a partial symptom of psychotic disorder that 
presents delusional symptoms, as we previously mentioned in 
a case report.11 Hozaki23 reported that cenesthopathy without 
psychiatric disorders is rare. In the present study, oral cen-
esthopathy without psychiatric disorder was not rare, which 
might be because of the difference of clinical setting between 
dentistry and psychiatry. Accordingly, our data are likely to 
reflect the patients’ characteristics, which actually distress the 
dentists. Interestingly, as to delusional infestation, which is 
experienced mainly by a dermatologist, it is consistent with 
our data that ~40% of patients are pure cases that are not the 
secondary symptoms of psychiatric diseases.24,25
One of the most important findings of dentists in the 
present study is that dental treatments in the acute phase of 
depression might be a risk factor for oral cenesthopathy, as 
suggested in Table 3. Oral cenesthopathy is known to be 
so intractable that we have only a 36% treatment efficacy. 
Other psychosomatic oral symptoms such as BMS and 
atypical odontalgia are still treatable, but some refractory 
cases still exist. Therefore, to prevent the trouble concerning 
psychosomatic oral symptoms, comprehending the situation 
of the psychiatric disorder and obtaining adequate informed 
consent are required.
Under the clinical entity of DDST, some case reports and 
reviews suggested that antidepressants, antipsychotic drugs, 
and electroconvulsive therapy (ECT) are effective. When only 
the oral symptoms are present, paroxetine,12 fluvoxamine,13 
amitriptyline,13,14 sulpiride,14 risperidone,13,15 olanzapine,13 
perospirone,11 aripiprazole,16 and ECT11,26 were reported to 
be effective. In this study, aripiprazole was the most effec-
tive medicine, especially in low doses. At the same time, 
various drugs including amitriptyline, mirtazapine, and 
other antidepressants were also effective in some cases. 
The disproportionality of the drug response may suggest 
the heterogeneity of a clinical entity of DDST. Any history 
of mental disorder and a duration of illness over 18 months, 
which were detected as significant risk factors for clinical 
course using binomial logistic regression analysis, and onset 
age might be factors for classifying oral cenesthopathy or 
DDST into clinically meaningful disease units.
We recently found the asymmetrical rCBF pattern between 
the right and left hemispheres with right side dominance using 
single-photon emission computed tomography.22 The asymmet-
rical rCBF pattern was common regardless of the comorbidity of 
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may again have existed in this clinical entity, because the asym-
metrical rCBF pattern was also not homogeneous in the research. 
More studies that combine clinical data and brain imaging are 
needed to understand oral cenesthopathy better.
This study has several limitations. Because the psychiatric 
history was collected by referral letter and our examination, 
some psychiatric disorders may have remained undiagnosed. 
However, as shown in the “Results” section, almost all 
patients brought the referral letter, and we consulted with 
a psychiatrist about suspicious patients. Hence, the hidden 
psychiatric disorders may be few. Another limitation of this 
study is the duration of illness which was 40.12 months. 
This long duration might increase the number of the patients 
with histories of depression. But the number of patients 
whose depression was developed after the onset of oral 
cenesthopathy is not frequent.
Conclusion
Patients with oral cenesthopathy in our clinic were pre-
dominantly elderly female patients, and there were various 
complaints. Considering the psychiatric history, oral cenest-
hopathy might not be merely a partial symptom of psychotic 
disorders that present delusional symptoms. Dental treatment 
in the acute phase of depression might be a risk factor of oral 
cenesthopathy. Therefore, comprehending the situation of 
psychiatric disorder and obtaining adequate informed con-
sent might be required to prevent the trouble concerning oral 
cenesthopathy. Not only dentists but also the psychiatrists 
should be aware of this. Further research studies using brain 
imaging and reliable assessment tools are warranted.
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